The Medicines Company Aims For Mid-2008 Cleviprex Launch
This article was originally published in The Pink Sheet Daily
Executive Summary
The third-generation, acute care calcium channel blocker’s FDA user fee date is in May 2008, COO Kelley tells “The Pink Sheet” DAILY.